Skip to main content

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
Cancel
×
×
Home
  • Home
Chapter
  • Print publication year: 2012
  • Online publication date: July 2012

Chapter 4 - Reducing perioperative cardiac risk

Export citation
Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Core Topics in Vascular Anaesthesia
  • Online ISBN: 9780511736537
  • Book DOI: https://doi.org/10.1017/CBO9780511736537
Please enter your name
Please enter a valid email address
Who would you like to send this to *

CAPTCHA *

Skip to the audio challenge
×

References

1. DevereauxPJ, GoldmanL, CookDJ, et al. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. Can Med Ass J 2005;173:627–34.
2. BiccardBM, RodsethRN.The pathophysiology of perioperative myocardial infarction. Anaesthesia 2010;65:733–41.
3. ChassotPG, DelabaysA, SpahnDR.Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 2007;99:316–28.
4. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71–86.
5. ColletJP, MontalescotG, BlanchetB, et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 2004;110:2361–7.
6. BurgerW, ChemnitiusJM, KneisslGD, RuckerG.Low-dose aspirin for secondary cardiovascular prevention: cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation – review and meta-analysis. J Intern Med 2005;257:399–414.
7. OscarssonA, GuptaA, FredriksonM, et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth 2010;104:305–12.
8. RoblessP, MikhailidisDP, StansbyG.Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease. Br J Surg 2001;88:787–800.
9. LindbladB, PerssonNH, TakolanderR, BergqvistD.Does low-dose acetylsalicylic acid prevent stroke after carotid surgery? A double-blind, placebo-controlled randomized trial. Stroke 1993;24:1125–8.
10. AlbaladejoP, GeeraertsT, FrancisF, et al. Aspirin withdrawal and acute lower limb ischemia. Anesth Analg 2004;99:440–3.
11. NeilipovitzDT, BrysonGL, NicholG.The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis. Anesth Analg 2001;93:573–80.
12. McCollumC, AlexanderC, KenchingtonG, FranksPJ, GreenhalghR.Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial. J Vasc Surg 1991;13:150–61; discussion 161–2.
13. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329–39.
14. HalkesPH, van GijnJ, KappelleLJ, KoudstaalPJ, AlgraA.Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006;367:1665–73.
15. PayneDA, HayesPD, JonesCI, et al. Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet action. J Vasc Surg 2002;35:1204–9.
16. ChenL, BraceyAW, RadovancevicR, et al. Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg 2004;128:425–31.
17. SavonittoS, D'UrbanoM, CaraccioloM, et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of ‘bridging’ antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br J Anaesth 2010;104:285–91.
18. HorlockerTT, WedelDJ, BenzonH, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003;28:172–97.
19. SpahnDR, HowellSJ, DelabaysA, ChassotPG.Coronary stents and perioperative antiplatelet regimen: dilemma of bleeding and stent thrombosis. Br J Anaesth 2006;96:675–7.
20. National Institute for Health and Clinical Excellence. Statins for the Prevention of Cardiovascular Events, Technology Appraisal 94. London: NICE, 2006. Available from www.nice.org.uk/page.aspx?o=TA094guidance.
21. HindlerK, ShawAD, SamuelsJ, et al. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 2006;105:1260–72; quiz 1289–90.
22. KapoorAS, KanjiH, BuckinghamJ, DevereauxPJ, McAlisterFA.Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ 2006;333:1149.
23. DunkelgrunM, BoersmaE, SchoutenO, et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). Ann Surg 2009;249:921–6.
24. SchoutenO, BoersmaE, HoeksSE, et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med 2009;361:980–9.
25. DurazzoAE, MachadoFS, IkeokaDT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 2004;39:967–75; discussion 975–6.
26. Heart Protection Study. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20 536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg 2007;45:645–53; discussion 653–4.
27. PadayacheeL, RodsethRN, BiccardBM.A meta-analysis of the utility of C-reactive protein in predicting early, intermediate-term and long term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia 2009;64:416–24.
28. Le ManachY, GodetG, CoriatP, et al. The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth Analg 2007;104:1326–33.
29. BiccardBM.Investigation of predictors of increased creatine kinase levels following vascular surgery and the association with perioperative statin therapy. Cardiovasc J Afr 2009;20:187–91.
30. ZauggM, TaglienteT, LucchinettiE, et al. Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology 1999;91:1674–86.
31. LandesbergG.Monitoring for myocardial ischemia. Best Pract Res Clin Anaesthesiol 2005;19:77–95.
32. FeringaHH, BaxJJ, BoersmaE, et al. High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients. Circulation 2006;114(1 Suppl):I344–9.
33. LandesbergG, MosseriM, ZahgerD, et al. Myocardial infarction after vascular surgery: the role of prolonged stress-induced, ST depression-type ischemia. J Am Coll Cardiol 2001;37:1839–45.
34. BangaloreS, WetterslevJ, PraneshS, et al. Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis. Lancet 2008;372:1962–76.
35. PeriOperative ISchaemic Evaluation. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371:1839–47.
36. BeattieWS, WijeysunderaDN, KarkoutiK, McCluskeyS, TaitG.Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials. Anesth Analg 2008;106:1039–48.
37. LindenauerPK, PekowP, WangK, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005;353:349–61.
38. ZauggM, BestmannL, WackerJ, et al. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study – a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology 2007;107:33–44.
39. GilesJW, SearJW, FoexP.Effect of chronic beta-blockade on perioperative outcome in patients undergoing non-cardiac surgery: an analysis of observational and case control studies. Anaesthesia 2004;59:574–83.
40. ShammashJB, TrostJC, GoldJM, et al. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients. Am Heart J 2001;141:148–53.
41. HoeksSE, Scholte Op ReimerWJ, van UrkH, et al. Increase of 1-year mortality after perioperative beta-blocker withdrawal in endovascular and vascular surgery patients. Eur J Vasc Endovasc Surg 2007;33:13–19.
42. WallaceAW, GalindezD, SalahiehA, et al. Effect of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. Anesthesiology 2004;101:284–93.
43. OliverMF, GoldmanL, JulianDG, HolmeI.Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology 1999;91:951–61.
44. WijeysunderaDN, NaikJS, BeattieWS.Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med 2003;114:742–52.
45. WijeysunderaDN, BeattieWS.Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: a meta-analysis. Anesth Analg 2003;97:634–41.
46. KertaiMD, WesterhoutCM, VargaKS, AcsadyG, GalJ.Dihydropiridine calcium-channel blockers and perioperative mortality in aortic aneurysm surgery. Br J Anaesth 2008;101:458–65.
47. KheterpalS, KhodaparastO, ShanksA, O'ReillyM, TremperKK.Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery. J Cardiothorac Vasc Anesth 2008;22:180–6.
48. CittanovaML, ZubickiA, SavuC, et al. The chronic inhibition of angiotensin-converting enzyme impairs postoperative renal function. Anesth Analg 2001;93:1111–15.
49. RailtonCJ, WolpinJ, Lam-McCullochJ, BeloSE.Renin–angiotensin blockade is associated with increased mortality after vascular surgery. Can J Anaesth 2010;57:736–44.
50. Shchukin IV, VachevAN, SurkovaEA, et al. [The role of beta-adrenoblockers and If-inhibitor ivabradine in lowering of rate of development of cardiac complications after carotid endarterectomy.]Kardiologiia 2008;48:56–9.
51. McFallsEO, WardHB, MoritzTE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004;351:2795–804.
52. PoldermansD, SchoutenO, VidakovicR, et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol 2007;49:1763–9.
53. BiccardBM, RodsethRN.A meta-analysis of the prospective randomised trials of coronary revascularisation before noncardiac vascular surgery with attention to the type of coronary revascularisation performed. Anaesthesia 2009;64:1105–13.
54. WardHB, KellyRF, ThottapurathuL, et al. Coronary artery bypass grafting is superior to percutaneous coronary intervention in prevention of perioperative myocardial infarctions during subsequent vascular surgery. Ann Thorac Surg 2006;82:795–800; discussion 800–1.
55. HertzerNR, YoungJR, BevenEG, et al. Late results of coronary bypass in patients with infrarenal aortic aneurysms: The Cleveland Clinic Study. Ann Surg 1987;205:360–7.
56. LandesbergG, BerlatzkyY, BocherM, et al. A clinical survival score predicts the likelihood to benefit from preoperative thallium scanning and coronary revascularization before major vascular surgery. Eur Heart J 2007;28:533–9.
57. VicenziMN, MeislitzerT, HeitzingerB, et al. Coronary artery stenting and non-cardiac surgery: a prospective outcome study. Br J Anaesth 2006;96:686–93.
58. SerruysPW, KutrykMJ, OngAT.Coronary-artery stents. N Engl J Med 2006;354:483–95.
59. LagerqvistB, JamesSK, StenestrandU, et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007;356:1009–19.
60. IakovouI, SchmidtT, BonizzoniE, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126–30.
61. SchoutenO, van DomburgRT, BaxJJ, et al. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 2007;49:122–4.
62. KaluzaGL, JosephJ, LeeJR, RaiznerME, RaiznerAE.Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000;35:1288–94.
63. SharmaAK, AjaniAE, HamwiSM, et al. Major noncardiac surgery following coronary stenting: when is it safe to operate?Catheter Cardiovasc Interv 2004;63:141–5.
64. AuerJ, BerentR, WeberT, EberB.Risk of noncardiac surgery in the months following placement of a drug-eluting coronary stent. J Am Coll Cardiol 2004;43:713; author reply 714–15.
65. McFaddenEP, StabileE, RegarE, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519–21.
66. ComptonPA, ZankarAA, AdesanyaAO, BanerjeeS, BrilakisES.Risk of noncardiac surgery after coronary drug-eluting stent implantation. Am J Cardiol 2006;98:1212–13.
67. FleisherLA, BeckmanJA, BrownKA, et al. ACC/AHA 2007 Guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007;116:1971–96.
68. PoldermansD, BaxJJ, BoersmaE, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur Heart J 2009;30:2769–812.
69. MonacoM, StassanoP, Di TommasoL, et al. Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients: a prospective, randomized study. J Am Coll Cardiol 2009;54:989–96.
Cancel
Confirm
×